Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroid responsive fludarabine pulmonary toxicity.

George S Stoica1, Harly E Greenberg, Leonard J Rossoff

  • 1Division of Pulmonary and Critical Care Medicine, Long Island Jewish Medical Center, New Hyde Park, New York 11042-1101, U.S.A.

American Journal of Clinical Oncology
|August 2, 2002
PubMed
Summary

Fludarabine monophosphate effectively treats lymphoproliferative disorders and chronic lymphocytic leukemia by inhibiting DNA synthesis. This purine nucleoside antimetabolite induces cancer cell death via apoptosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insular routing to orbitofrontal cortex enables breathing awareness.

medRxiv : the preprint server for health sciences·2025
Same author

Comparison of obstructive sleep apnoea prevalence and severity across WHO pulmonary hypertension groups.

BMJ open respiratory research·2022
Same author

Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension.

Sleep & breathing = Schlaf & Atmung·2022
Same author

Respiratory effort-related arousals contribute to sympathetic modulation of heart rate variability.

Sleep & breathing = Schlaf & Atmung·2013
Same author

Idiopathic pneumothorax, or not?

The Lancet. Infectious diseases·2004
Same author

Legionella micdadei infection presenting as severe secretory diarrhea and a solitary pulmonary mass.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2004

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Fludarabine monophosphate is a key purine nucleoside antimetabolite.
  • It is utilized in treating lymphoproliferative disorders and chronic lymphocytic leukemia.

Observation:

  • Fludarabine monophosphate is a derivative of 9-beta-D-arabinofuranosyl adenine (ara-A, vidarabine).
  • Its chemical structure is the 2-fluoro, 5' phosphate derivative.

Findings:

  • The mechanism of action involves the inhibition of DNA synthesis.
  • It exhibits cytolytic effects through the induction of endonuclease-independent apoptosis.

Implications:

  • Fludarabine monophosphate represents a significant therapeutic agent in cancer treatment.

Related Experiment Videos

  • Understanding its mechanism enhances targeted cancer therapy development.